No First Use of Nuclear Weapons, & More from CRS
Recent reports from the Congressional Research Service that have not been publicly released include the following.
U.S. Nuclear Weapons Policy: Considering “No First Use”, CRS Insight, August 16, 2016
Coordinated Party Expenditures in Federal Elections: An Overview, updated August 15, 2016
Introduction to FEMA’s National Flood Insurance Program (NFIP), August 16, 2016
The United Arab Emirates (UAE): Issues for U.S. Policy, updated August 16, 2016
Airline Passenger Rights: The Federal Role in Aviation Consumer Protection, August 17, 2016
Legal Status of CEQ’s Final Guidance on Climate Change in Environmental Reviews under NEPA, CRS Legal Sidebar, August 17, 2016
U.S. Trade Deficit and the Impact of Changing Oil Prices, updated August 16, 2016
General Policy Statements: Legal Overview, April 14, 2016
Dude, Where’s My Jurisdiction? Congressional Efforts to Strip Federal Courts of Jurisdiction, CRS Legal Sidebar, August 17, 2016
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.